EpiAxis Therapeutics has been announced among the first batch of companies that will present at Wholesale Investor’s fifth annual Emergence 2022 event in March.
It’s the first time the event has been held live in two years. The annual Emergence event brings together high-growth companies from fintech, renewable energy, biotech and ecommerce to showcase their investment opportunities. Companies included in the first announcement alongside EpiAxis include SelfWealth, Novapep, Long Pipes, EG Funds and Horizon 3 Biotech.
“We are delighted to be part of this group announcement with Wholesale Investor and look forward to presenting EpiAxis at the event, sharing our progress on the development of novel therapeutics for metastatic disease,” said EpiAxis CEO Dr Jeremy Chrisp.
Wholesale Investor events have connected $187million of capital in just under four years, showcased to more than 29,000 high net-worth investors and investment groups at events spanning nine countries and 12 cities. EpiAxis became part of the investment platform in October. Our membership kicked off with Dr Chrisp presenting at Wholesale Investor’s STEM 2021 Conference. It was a valuable opportunity to network with investors interested in biotech and discuss how our epigenetic science aims to maintain and extend cancer remission, with low side effects
Emergence 2022 will be held from March 9-11, 2022.